Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world re-opens for business. However, others may turn out to be classic value traps. Read on for our usual insightful comment.
James Halstead: another dividend increase
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Anexo
Cosmetic ambiguity | Public sector winner and loser
News covered here includes our assessment of the latest trading update from a cosmetics group which…
Episode 16 of the Investor’s Champion Podcast
In this episode of the Investor’s Champion Podcast Chris and Lee run through key news from…
More on Brickability
Stunning results | Cash flow quirk | AI opportunity
The results are coming thick and fast and there are some crackers covered here, dispelling the…
Appealing dividends | US healthcare | Debt concerns
Hot on the heels of its first acquisition, a retailer of fresh cream cakes is chancing…
More on Duke Capital
BIG litigation | Big margins | Big dividends
News covered here includes our coverage of excellent results from a specialist medical device company, which…
The penny drops | Cash delights | Another AIM takeover
Small cap news covered in our update here includes our forthright assessment of the latest update…
More on Ideagen PLC
Bonkers deal of the week or another nifty acquisition?
The shares of technology stocks are plummeting, but that hasn’t stopped this AIM company paying what…
Strong updates to enjoy
Results and updates covered here include those of several consistent (and highly-rated) performers, but a potential…
More on iEnergizer
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
More on ITV
Income Boosters: cash-backed dividends with growth potential
Earnings season has been free of major drama for our high yielders, despite the uncertain macroeconomic…
Income Boosters: making progress in mixed markets
July was a busy month for our high yield Income Boosters portfolio, with five companies reporting during…
More on James Halstead
Another upgrade | 49 years of dividend increases
News covered in our update here include our thoughts on another strong trading update from a…
Double digit growth | Stonking Small Cap updates
Our coverage here includes a review of stunning results from a manufacturer of products for the…
More on Manolete Partners
Episode 39 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, hosts Chris and Lee dive into the controversial…
Improving returns | Questionable business models
A software provider whose results we assess here continues to recover from the consequences of a…
More on WH Smith
Wine worries | Construction woes | Travel delights
News covered here includes our assessment of trading updates from AIM’s online wine retailers. While one…
Episode 21 of the Investor’s Champion Podcast
In this episode of the Investors Champion podcast, hosts Chris and Lee discuss the challenges faced…
